42 U.S.C. § 1320f-7

Current through P.L. 118-106 (published on www.congress.gov on 10/04/2024)
Section 1320f-7 - Limitation on administrative and judicial review

There shall be no administrative or judicial review of any of the following:

(1) The determination of a unit, with respect to a drug or biological product, pursuant to section 1320f(c)(6) of this title.
(2) The selection of drugs under section 1320f-1(b) of this title, the determination of negotiation-eligible drugs under section 1320f-1(d) of this title, and1 the determination of qualifying single source drugs under section 1320f-1(e) of this title the2 application of section 1320f-1(f) of this title,.3
(3) The determination of a maximum fair price under subsection (b) or (f) of section 1320f-3 of this title.
(4) The determination of renegotiation-eligible drugs under section 1320f-3(f)(2) of this title and the selection of renegotiation-eligible drugs under section 1320f-3(f)(3) of this title.

1So in original. The word "and" probably should not appear.

2So in original. Probably should be preceded by ",and".

3So in original.

42 U.S.C. § 1320f-7

Aug. 14, 1935, ch. 531, title XI, §1198, as added and amended Pub. L. 117-169, title I, §§11001(a), Aug. 16, 2022, 11002, Aug. 16, 2022, 136 Stat. 1851, 1861.

EDITORIAL NOTES

AMENDMENTS2022-Par. (2). Pub. L. 117-169, §11002(a)(5), which directed the amendment of subsec. (b)(2) of this section by inserting "the application of section 1320f-1(f) of this title," after "section 1320f-1(e) of this title", was executed by making the insertion in par. (2) to reflect the probable intent of Congress.